An evaluation of methods for determining reference intervals for light transmission platelet aggregation tests on samples with normal or reduced platelet counts

Thrombosis and Haemostasis

Volumn 100, Issue 1, 2008, Pages 134-145

  Hayward, Catherine P M ^a   Moffat, Karen A ^b   Pai, Menaka ^b   Liu, Yang ^b   Seecharan, Jodi ^b   McKay, Heather ^b   Webert, Kathryn E ^b   Cook, Richard J ^b   Heddle, Nancy M ^b  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b NONE

Author keywords

Maximal aggregation; Platelet aggregation; Platelet function; Reference intervals; Thrombocytopenia

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ARACHIDONIC ACID; COLLAGEN; RISTOCETIN;

ARTICLE; BERNARD SOULIER DISEASE; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REFERENCE VALUE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; BLOOD PLATELETS; CELL SIZE; COLLAGEN; DATA INTERPRETATION, STATISTICAL; EPINEPHRINE; FEASIBILITY STUDIES; HUMANS; LIGHT; PLATELET AGGREGATION; PLATELET COUNT; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; REFERENCE VALUES; RISTOCETIN; STATISTICS, NONPARAMETRIC; THROMBOCYTOPENIA;

EID: 46749112199     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-03-0183     Document Type: Article

References (19)

1. Hayward CP, Rao AK, Cattaneo M. Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment. Haemophilia 2006; 12 (Suppl 3): 128-136.
2. Moffat KA, Ledford-Kraemer MR, Nichols WL, et al. Variability in clinical laboratory practice in testing for disorders of platelet function: results of two surveys of the North American Specialized Coagulation Laboratory Association. Thromb Haemost 2005; 93: 549-553.
3. Hayward CP, Eikelboom J. Platelet function testing: quality assurance. Semin Thromb Hemost 2007; 33: 273-282.
4. Nurden P, Nurden AT. Congenital disorders associated with platelet dysfunctions. Thromb Haemost 2008; 99: 253-263.
5. Guidelines on platelet function testing. The British Society for Hematology, BCSH Haemostasis and Thrombosis Task Force. J Clin Path 1998; 41: 1322-1330.
6. Jennings LK, McCabe White M. Platelet aggregation. In: Platelets. 2 ed. Amsterdam: Elsevier; 2007: 495-507.
7. Taylor JM, Cumberland WG, Meng X, et al. Normal range estimation for repeated immunologic measures. Clin Diagn Lab Immunol 1996; 3: 139-142.
8. Gupta PK, Charan VD, Saxena R. Spectrum of von Willebrand disease and inherited platelet function disorders amongst Indian bleeders. Ann Hematol 2007; 86: 403-407.
9. Philipp CS, Dilley A, Miller CH, et al. Platelet functional defects in women with unexplained menorrhagia. J Thromb Haemost 2003; 1: 477-484.
10. Mikhail S, Varadarajan R, Kouides P. The prevalence of disorders of haemostasis in adolescents with menorrhagia referred to a haemophilia treatment centre. Haemophilia 2007; 13: 627-632.
11. Quiroga T, Goycoolea M, Panes O, et al. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica 2007; 92: 357-365.
12. Bray PF, Mathias RA, Faraday N, et al. Heritability of platelet function in families with premature coronary artery disease. J Thromb Haemost 2007; 5: 1617-1623.
13. Yee DL, Sun CW, Bergeron AL, et al. Aggregometry detects platelet hyperreactivity in healthy individuals. Blood 2005; 106: 2723-2729.
14. Gurbel PA, Becker RC, Mann KG, et al. Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol 2007; 50: 1822-1834.
15. Cattaneo M, Lecchi A, Zighetti ML, et al. Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. Haematologica 2007; 92: 694-697.
16. Linnemann B, Schwonberg J, Mani H, et al. Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary. J Thromb Haemost 2008; 6: 677-683.
17. Favaloro EJ, Bonar R, Meiring M, et al. 2B or not 2B? Disparate discrimination of functional VWF discordance using different assay panels or methodologies may lead to success or failure in the early identification of type 2B VWD. Thromb Haemost 2007; 98: 346-358.
18. Diamandis M, Veljkovic DK, Maurer-Spurej E, et al. The Quebec Platelet Disorder: Features, pathogenesis and treatment. Blood Coagulation Fibrinolysis 2008; 19: 109-119.
19. Horn PS, Pesce AJ. Reference intervals: an update. Clin Chim Acta 2003; 334: 5-23.